Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 9, 2009

ICON Tasked with Clinical Trial Site Setup and Monitoring for Lilly in Europe

  • ICON will manage Eli Lilly’s clinical trial site setup and monitoring in Europe. This arrangement follows Lilly’s selection of ICON to manage its clinical data management business outside the U.S., which was announced in November 2008.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »